Biotech
Biotech and pharmaceutical dealmaking has surpassed $106 billion in 2026, driven by the search for innovative therapies in oncology, obesity, rare diseases and precision medicine. For healthcare leaders, the trend highlights how the next generation of treatments is increasingly moving from biotech laboratories into global healthcare markets through strategic acquisitions.
This month, we’re showcasing eight healthcare executives to watch as they drive innovation in pharmacy, technology, and HR
